A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus

Clinical Immunology

Volumn 150, Issue 2, 2014, Pages 192-200

  Grammatikos, Alexandros P ^a   Kyttaris, Vasileios C ^a   Kis Toth, Katalin ^a   Fitzgerald, Lisa M ^a   Devlin, Amy ^a   Finnell, Michele D ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; CD70; Diagnostic; Flare; IL10; OAS2

Indexed keywords

CD70 ANTIGEN; INTERLEUKIN 10; OAS2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

BIOMARKERS; CD70; DIAGNOSTIC; FLARE; IL10; OAS2;

2',5'-OLIGOADENYLATE SYNTHETASE; ADULT; AGED; ANTIGENS, CD70; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRANSCRIPTOME;

EID: 84892458522     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.12.002     Document Type: Article

References (37)

1. Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365:2110-2121.
2. Sturfelt G., Nived O. Instruments to measure disease activity in systemic lupus erythematosus - is our net tight enough to catch the hydra?. J. Rheumatol. 2011, 38:3-4.
3. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum. 2004, 50:3418-3426.
4. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
5. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., Jatkoe T., Berns E.M., Atkins D., Foekens J.A. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
6. McKinney E.F., Lyons P.A., Carr E.J., Hollis J.L., Jayne D.R., Willcocks L.C., Koukoulaki M., Brazma A., Jovanovic V., Kemeny D.M., Pollard A.J., Macary P.A., Chaudhry A.N., Smith K.G. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 2010, 16:586-591. (581p following 591).
7. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723.
8. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., FitzGerald J.D., Park G.S., Dong X., Chen W., Kim M.H., Weng H.H., Furst D.E., Gorn A., McMahon M., Taylor M., Brahn E., Hahn B.H., Tsao B.P. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2951-2962.
9. Nikpour M., Dempsey A.A., Urowitz M.B., Gladman D.D., Barnes D.A. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann. Rheum. Dis. 2008, 67:1069-1075.
10. Kyttaris V.C., Tsokos G.C. Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus. Curr. Opin. Rheumatol. 2011, 23:449-453.
11. Grammatikos A.P., Tsokos C.G. T cell abnormalities in patients with SLE (systemic lupus erythematosus). World Hell. Biomed. News 2011, 2:7-11.
12. Crispin J.C., Kyttaris V.C., Terhorst C., Tsokos G.C. T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 2010, 6:317-325.
13. Lo M.S., Tsokos G.C. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Ann. N. Y. Acad. Sci. 2012, 1247:138-152.
14. Grammatikos A.P., Tsokos G.C. Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol. Med. 2012, 18:101-108.
15. Juang Y.T., Peoples C., Kafri R., Kyttaris V.C., Sunahori K., Kis-Toth K., Fitzgerald L., Ergin S., Finnell M., Tsokos G.C. A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report. Lupus 2011, 20:243-249.
16. Troyanskaya O., Cantor M., Sherlock G., Brown P., Hastie T., Tibshirani R., Botstein D., Altman R.B. Missing value estimation methods for DNA microarrays. Bioinformatics 2001, 17:520-525.
17. Gould J., Getz G., Monti S., Reich M., Mesirov J.P. Comparative gene marker selection suite. Bioinformatics 2006, 22:1924-1925.
18. Speybroeck N. Classification and regression trees. Int. J. Public Health 2012, 57:243-246.
19. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14863-14868.
20. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., Mesirov J.P. GenePattern 2.0. Nat. Genet. 2006, 38:500-501.
21. Crispin J.C., Liossis S.N., Kis-Toth K., Lieberman L.A., Kyttaris V.C., Juang Y.T., Tsokos G.C. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol. Med. 2010, 16:47-57.
22. Fernandez D., Bonilla E., Phillips P., Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr. Metab. Immune Disord. Drug Targets 2006, 6:305-311.
23. Crispin J.C., Kyttaris V.C., Juang Y.T., Tsokos G.C. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol. 2008, 29:110-115.
24. Moulton V.R., Tsokos G.C. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex. J. Biol. Chem. 2010, 285:12490-12496.
25. Breiman L., Friedman J., Stone C.J., Olshen R.A. Classification and Regression Trees 1984, Chapman and Hall/CRC, Washington DC.
26. Landolt-Marticorena C., Bonventi G., Lubovich A., Ferguson C., Unnithan T., Su J., Gladman D.D., Urowitz M., Fortin P.R., Wither J. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 2009, 68:1440-1446.
27. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2610-2615.
28. Kirou K.A., Lee C., George S., Louca K., Papagiannis I.G., Peterson M.G., Ly N., Woodward R.N., Fry K.E., Lau A.Y., Prentice J.G., Wohlgemuth J.G., Crow M.K. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004, 50:3958-3967.
29. Valasek M.A., Repa J.J. The power of real-time PCR. Adv. Physiol. Educ. 2005, 29:151-159.
30. Moulton V.R., Tsokos G.C. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res. Ther. 2011, 13:207.
31. Kyttaris V.C., Krishnan S., Tsokos G.C. Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function. Autoimmunity 2006, 39:705-709.
32. Rhodes B., Vyse T.J. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology 2008, 47:1603-1611.
33. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S.K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 1996, 97:2063-2073.
34. Csiszar A., Nagy G., Gergely P., Pozsonyi T., Pocsik E. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 2000, 122:464-470.
35. Nguyen H., Weng N.P. IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span. J. Leukoc. Biol. 2010, 87:43-49.
36. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., Richardson B. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 2004, 50:1850-1860.
37. Tang J., Gu Y., Zhang M., Ye S., Chen X., Guo Q., Qian J., Bao C., Chen S., Shen N. Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients. Lupus 2008, 17:805-813.